Chair of Translational Oncology

Our main focus is on:

  • Identification of molecular targets and development of targeted therapies for the treatment of tumors of the lymphohematopoietic system
  • Development of immunotherapies with bispecific antibodies
  • Early Clinical Development: planning and conduction of clinical phase -I, -I/II trials in the field of Oncology
  • Head of the Comprehensive Cancer Center Mainfranken
  • Head of the Early Clinical Trial Unit (ECTU) and
  • Trial Office of the CCC Mainfranken
  • Head of the Division Hemato-Oncology of the Department of Internal Medicine II
  • Head of the Division of Hematology/Oncology of the Department of Internal Medicine II